TAS1R2 and metabolic dysfunction-associated steatohepatitis: When we subclassified our cohort of patients according to the hepatic histopathological classification into NL, SS and NASH, we did not observe differences in JRE of TAS1R2 (Figure 3B), TAS2R14 (Figure 3D) or TAS2R38 (Figure 3F).